We sought to leverage our Sglt2-Cre; ASPSCR1-TFE3LSL/+ model to provide insight into the molecular genetics of tRCC. Here, SLC5A2 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.